Home

Brendan Hannah, Chief Business Officer and COO: Quince Therapeutics QNCX Buy · Filed 24/08/21

Trade details

Type
Insider buy
Amount
$1,249.9
Shares · price
2,155 sh · $0.58 a share
Held after
259,771 sh
Trade date
24/08/19
Filed
24/08/21
Days to filing
2 days

First buy in 1 years

Since the last buy
1 years
Last buy
23/08/08
Insiders buying this week
2 insiders
Holding change
+0.8%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/20~24/09/18

Brendan Hannah's recent trades

  • Brendan Hannah

    BuyQuince Therapeutics

    $14.8K

    Filed 24/08/21

  • Brendan Hannah

    BuyQuince Therapeutics

    $1,391

    Filed 24/08/21

  • Brendan Hannah

    BuyQuince Therapeutics

    $2,054

    Filed 24/08/21

  • Brendan Hannah

    BuyQuince Therapeutics

    $3,100

    Filed 24/08/21

  • Brendan Hannah

    BuyQuince Therapeutics

    $1,525

    Filed 24/08/21

Brendan Hannah, COO — bought $1,250 of Quince Therapeutics QNCX · 2,155 sh @ $0.58 | Whalegun